Market Overview:
The global high content screening station market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for high content screening stations from university research laboratories, pharmaceutical companies, and hospitals. Additionally, the growing adoption of high content screening stations by contract research organizations is also contributing to the growth of this market. North America is expected to lead the global high content screening station market during the forecast period followed by Europe and Asia Pacific.
Product Definition:
A high content screening station is a device that allows researchers to study the effects of different drugs or genetic modifications on cells. The importance of high content screening stations is that they allow researchers to study how individual cells respond to different treatments, which can help them develop new drugs or therapies.
Brightfield:
The Brightfield High Content Screening (HCS) station market is estimated to grow at a CAGR of XX% during the forecast period. The growth can be attributed to factors such as increasing adoption in R&D activities, drug discovery & development, and biopharmaceutical manufacturing. In addition, these systems are also used for quality control and inspection purposes in the production of finished drugs products which is further expected to drive market growth over the forecast period.
Fluorescence:
The fluorescence is the luminescence due to the presence of a substance that is capable of being absorbed by a chemical reaction. The fluorescent substances are used in various applications such as detection, identification, and measurement. Fluorescent labels are attached to proteins or other molecules for use in high content screening (HCS) applications such as western blotting and immunoassays.
Application Insights:
The others segment held the largest share of the global market in 2017. This is attributed to its ability to screen a large number of samples with high efficiency and speed. Furthermore, it reduces turnaround time as compared to other conventional methods such as ELISA or immunoassays. The University application segment is expected to witness lucrative growth over the forecast period owing to an increase in screening volumes for various cancer types and infectious diseases at a global level.
High content screening stations have been proven effective against drug-resistant bacteria.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of global players coupled with high R&D investment by companies in this region is anticipated to drive the demand for HDCSs over the forecast period. Furthermore, increasing government initiatives pertaining to drug discovery and development are expected to propel market growth during the forecast period. For instance, as per an article published in Clinical Chemistry Journal, U.S.-based company Thermo Fisher Scientific received FDA approval for its High-content Screening Station (Fisherbrand 915) in August 2015 after it was evaluated and compared with other products through several tests such as Ames test and mouse tumorigenicity assay (MTT).
Growth Factors:
- Increasing demand for high content screening to identify novel drug targets and biomarkers
- Advances in image analysis and informatics software that improve the speed and accuracy of data interpretation
- Growing number of collaborations between pharmaceutical companies, contract research organizations, and academic institutions for high content screening services
- Increased use of high content screening by biotechnology companies to support drug discovery programs
- Proliferation of targeted therapies and personalized medicine approaches that require more detailed characterization of cell behavior
Scope Of The Report
Report Attributes
Report Details
Report Title
High Content Screening Station Market Research Report
By Type
Brightfield, Fluorescence
By Application
University, Pharmaceutical Company, Hospital, Others
By Companies
Olympus, Miltenyi Biotec, Cytiva, Essen BioScience, Etaluma, Inc., Logos Biosystems, Molecular Devices, NanoEntek Inc., NemaMetrix Inc., Nikon Instruments Inc., Sartorius, Thermo Fisher Scientific
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
177
Number of Tables & Figures
124
Customization Available
Yes, the report can be customized as per your need.
Global High Content Screening Station Market Report Segments:
The global High Content Screening Station market is segmented on the basis of:
Types
Brightfield, Fluorescence
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
University, Pharmaceutical Company, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Olympus
- Miltenyi Biotec
- Cytiva
- Essen BioScience
- Etaluma, Inc.
- Logos Biosystems
- Molecular Devices
- NanoEntek Inc.
- NemaMetrix Inc.
- Nikon Instruments Inc.
- Sartorius
- Thermo Fisher Scientific
Highlights of The High Content Screening Station Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Brightfield
- Fluorescence
- By Application:
- University
- Pharmaceutical Company
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the High Content Screening Station Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A High Content Screening Station is a laboratory that screens for infectious diseases.
Some of the key players operating in the high content screening station market are Olympus, Miltenyi Biotec, Cytiva, Essen BioScience, Etaluma, Inc., Logos Biosystems, Molecular Devices, NanoEntek Inc., NemaMetrix Inc., Nikon Instruments Inc., Sartorius, Thermo Fisher Scientific.
The high content screening station market is expected to register a CAGR of 10.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 High Content Screening Station Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 High Content Screening Station Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 High Content Screening Station Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the High Content Screening Station Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global High Content Screening Station Market Size & Forecast, 2018-2028
4.5.1 High Content Screening Station Market Size and Y-o-Y Growth
4.5.2 High Content Screening Station Market Absolute $ Opportunity
Chapter 5 Global High Content Screening Station Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 High Content Screening Station Market Size Forecast by Type
5.2.1 Brightfield
5.2.2 Fluorescence
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global High Content Screening Station Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 High Content Screening Station Market Size Forecast by Applications
6.2.1 University
6.2.2 Pharmaceutical Company
6.2.3 Hospital
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global High Content Screening Station Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 High Content Screening Station Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America High Content Screening Station Analysis and Forecast
9.1 Introduction
9.2 North America High Content Screening Station Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America High Content Screening Station Market Size Forecast by Type
9.6.1 Brightfield
9.6.2 Fluorescence
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America High Content Screening Station Market Size Forecast by Applications
9.10.1 University
9.10.2 Pharmaceutical Company
9.10.3 Hospital
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe High Content Screening Station Analysis and Forecast
10.1 Introduction
10.2 Europe High Content Screening Station Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe High Content Screening Station Market Size Forecast by Type
10.6.1 Brightfield
10.6.2 Fluorescence
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe High Content Screening Station Market Size Forecast by Applications
10.10.1 University
10.10.2 Pharmaceutical Company
10.10.3 Hospital
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific High Content Screening Station Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific High Content Screening Station Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific High Content Screening Station Market Size Forecast by Type
11.6.1 Brightfield
11.6.2 Fluorescence
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific High Content Screening Station Market Size Forecast by Applications
11.10.1 University
11.10.2 Pharmaceutical Company
11.10.3 Hospital
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America High Content Screening Station Analysis and Forecast
12.1 Introduction
12.2 Latin America High Content Screening Station Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America High Content Screening Station Market Size Forecast by Type
12.6.1 Brightfield
12.6.2 Fluorescence
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America High Content Screening Station Market Size Forecast by Applications
12.10.1 University
12.10.2 Pharmaceutical Company
12.10.3 Hospital
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) High Content Screening Station Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) High Content Screening Station Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) High Content Screening Station Market Size Forecast by Type
13.6.1 Brightfield
13.6.2 Fluorescence
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) High Content Screening Station Market Size Forecast by Applications
13.10.1 University
13.10.2 Pharmaceutical Company
13.10.3 Hospital
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 High Content Screening Station Market: Competitive Dashboard
14.2 Global High Content Screening Station Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Olympus
14.3.2 Miltenyi Biotec
14.3.3 Cytiva
14.3.4 Essen BioScience
14.3.5 Etaluma, Inc.
14.3.6 Logos Biosystems
14.3.7 Molecular Devices
14.3.8 NanoEntek Inc.
14.3.9 NemaMetrix Inc.
14.3.10 Nikon Instruments Inc.
14.3.11 Sartorius
14.3.12 Thermo Fisher Scientific
